In a retrospective study of four cohorts that included more than 1500 subjects, individuals positive for HAdV-36 antibodies had significantly lower fasting glucose and insulin levels and lower insulin resistance, independent of sex, age, race, and adiposity, compared to HAdV-36 seronegative individuals [8]. This evidence concerns the gene INS and Insulin resistance.